← Open Payments lookup

AMY THOMAS: Open Payments

NPI 1477163087 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,013 in 113 payments from 23 companies in 2025. Trend: 2023 $2,192 · 2024 $2,173 · 2025 $2,013

Food & beverage: $2,013
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.30$341
ABBVIE INC.13$299
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)10$199
Teva Pharmaceuticals USA, Inc.5$169
Otsuka America Pharmaceutical, Inc.10$154
Novo Nordisk Inc7$148
Alkermes, Inc.7$126
Janssen Pharmaceuticals, Inc5$86
AstraZeneca Pharmaceuticals LP2$61
Boehringer Ingelheim Pharmaceuticals, Inc.3$52

Products named: INGREZZA, VRAYLAR, CAPLYTA, AUSTEDO XR, REXULTI, ARISTADA, INVEGA SUSTENNA, FARXIGA.

Industry payments across OK — which companies pay providers there.